Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Stridebio Inc.
Headquarters: Durham, NC, United States of America
Website: http://www.stridebio.com
Year Founded: 2015
Status: Private
BioCentury | Sep 6, 2023
Management Tracks
Thaysen leaving Agilent to become CEO of Illumina
Plus: Josh Schimmer, Eric Schmidt join Cantor
BioCentury | Apr 25, 2023
Management Tracks
Sanofi’s Silvestri joins Ipsen as CMO
Plus: Malier leaving Kurma and updates from Harmony, ImmunoGen, Tarsus and more
BioCentury | Apr 6, 2023
Deals
April 5 Quick Takes: Farallon seeking change at Exelixis
Plus: molecular glue deals for Proxygen, BioTheryX and updates from Ginkgo and Protagonist
BioCentury | Jan 21, 2023
Discovery & Translation
Epigenome editing for X-linked diseases; plus a rapid platform for human mAb generation and more
BioCentury’s roundup of translational news
BioCentury | Jan 4, 2023
Management Tracks
Ex-Checkmate CEO Bash to lead ZielBio
Plus: Allogene’s Amado joins Zai Lab, and updates from bluebird bio, Rejuvenate, Novadip and more
BioCentury | Feb 8, 2022
Management Tracks
Lander resigns as Biden’s science adviser
Plus CMO Michaels out at Editas and updates from Tmunity, StrideBio, Adverum, iOmx, Curie and more
BioCentury | Nov 9, 2021
Management Tracks
Maraganore joins board at Beam
Plus: new CBO, board member at Caribou, Nordic, GT Biopharma and more
BioCentury | Apr 28, 2021
Management Tracks
Jefferson named FDA associate commissioner for external affairs; plus Surface, StrideBio, Himalaya and more
HHS named Erica Jefferson FDA associate commissioner for external affairs. Jefferson served as a spokesperson and acting assistant commissioner for media affairs at the agency during the Obama
BioCentury | Mar 17, 2021
Deals
March 17 Quick Takes: Merck-Amathus enter neurodegenerative disease collaboration; plus WuXi, Sana-Fujifilm, Rubius, Inflammatix, StrideBio and more
Amathus Therapeutics entered a strategic collaboration with Merck & Co. Inc. (NYSE:MRK) to develop small molecules for neurodegenerative diseases. Under the deal, Amathus will identify and conduct
BioCentury | Aug 19, 2020
Management Tracks
Rao to head Sobi R&D; plus new CMOs for Ikena, Agile, Nordic Nanovector and more
Swedish Orphan Biovitrum AB (SSE:SOBI) said Ravi Rao will succeed Milan Zdravkovic as head of R&D, effective Sept. 1. Rao joins the rare diseases company from Aeglea BioTherapeutics Inc.
Items per page:
1 - 10 of 19